PPD, Inc. has extended its digital clinical trial solutions to support biopharma companies’ research continuity initiatives in response to the COVID-19 pandemic.   The coronavirus pandemic increases challenges to the design and conduct of clinical studies, particularly the inability of patients to visit research sites. As part of the company’s digital strategy, PPD is collaborating with customers, regulatory authorities and business partners to deploy digital and virtual solutions.   New cli...